Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New findings in the area of breast cancer described
December 15th, 2005
Investigators in Ireland, France and Germany have published new breast cancer data. Study 1: Immunohistochemistry (IHC) for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by fluorescence in situ hybridization (FISH) than HercepTest in breast carcinoma. According to recent research from Ireland, "Her2 (c-erbB-2/neu) overexpression in breast carcinoma predicts response to the anti-Her2 monoclonal antibody, trastuzumab, and is associated with a poor prognosis. When considering patients for trastuzumab treatment, Her2 protein expression is measured by immunohistochemistry (IHC) and, where staining is equivocal, by...
Source: Women's Health Weekly (2005-12-15)
|
